Systems biology as an emerging paradigm in transfusion medicine

dc.contributorHáskólinn í Reykjavíken_US
dc.contributorReykjavik Universityen_US
dc.contributor.authorYurkovich, James
dc.contributor.authorBordbar, Aarash
dc.contributor.authorSigurjonsson, Olafur
dc.contributor.authorPalsson, Bernhard O.
dc.contributor.schoolTækni- og verkfræðideild (HR)en_US
dc.contributor.schoolSchool of Science and Engineering (RU)en_US
dc.date.accessioned2019-10-23T15:39:30Z
dc.date.available2019-10-23T15:39:30Z
dc.date.issued2018-03-07
dc.description.abstractBlood transfusions are an important part of modern medicine, delivering approximately 85 million blood units to patients annually. Recently, the field of transfusion medicine has started to benefit from the “omic” data revolution and corresponding systems biology analytics. The red blood cell is the simplest human cell, making it an accessible starting point for the application of systems biology approaches. In this review, we discuss how the use of systems biology has led to significant contributions in transfusion medicine, including the identification of three distinct metabolic states that define the baseline decay process of red blood cells during storage. We then describe how a series of perturbations to the standard storage conditions characterized the underlying metabolic phenotypes. Finally, we show how the analysis of high-dimensional data led to the identification of predictive biomarkers. The transfusion medicine community is in the early stages of a paradigm shift, moving away from the measurement of a handful of chosen variables to embracing systems biology and a cell-scale point of view.en_US
dc.description.sponsorshipThis research was supported by the European Research Council (ERC 232816), the National Heart, Lung, and Blood Institute (NHLBI R43HL123074), and the Landspitali University Hospital Research Fund.en_US
dc.description.versionPeer Revieweden_US
dc.format.extent31en_US
dc.identifier.citationYurkovich, J. T., Bordbar, A., Sigurjónsson, Ó. E., & Palsson, B. O. (2018). Systems biology as an emerging paradigm in transfusion medicine. BMC Systems Biology, 12(1), 31. https://doi.org/10.1186/s12918-018-0558-xen_US
dc.identifier.doi10.1186/s12918-018-0558-x
dc.identifier.issn1752-0509
dc.identifier.urihttps://hdl.handle.net/20.500.11815/1312
dc.language.isoenen_US
dc.publisherSpringer Natureen_US
dc.relation.ispartofseriesBMC Systems Biology;12(1)
dc.relation.urlhttp://link.springer.com/content/pdf/10.1186/s12918-018-0558-x.pdfen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectModelling and Simulationen_US
dc.subjectApplied Mathematicsen_US
dc.subjectMolecular Biologyen_US
dc.subjectStructural Biologyen_US
dc.subjectComputer Science Applicationsen_US
dc.subjectSystems biologyen_US
dc.subjectRed blood cellen_US
dc.subjectTransfusion medicineen_US
dc.subjectMetabolismen_US
dc.subjectStorage lesionen_US
dc.subjectLíkanagerðen_US
dc.subjectStærðfræðien_US
dc.subjectSameindalíffræðien_US
dc.subjectForriten_US
dc.subjectBlóðkornen_US
dc.subjectBlóðgjöfen_US
dc.subjectLyfen_US
dc.subjectEfnaskiptien_US
dc.titleSystems biology as an emerging paradigm in transfusion medicineen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dcterms.license© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stateden_US

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
s12918-018-0558-x.pdf
Stærð:
829.58 KB
Snið:
Adobe Portable Document Format
Description:
Publisher's version (útgefin grein)

Undirflokkur